• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast.三种特异性β(1,3)葡聚糖合酶抑制剂家族在裂殖酵母野生型和抗性菌株中的差异活性。
J Biol Chem. 2011 Feb 4;286(5):3484-96. doi: 10.1074/jbc.M110.174300. Epub 2010 Nov 29.
2
Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)beta-D-glucan synthesis in Saccharomyces cerevisiae.芽殖酵母和裂殖酵母中对丘疹霉素B的抗性:酿酒酵母中参与(1,3)β-D-葡聚糖合成的一个基因的分离与特性分析
J Bacteriol. 1995 Oct;177(20):5732-9. doi: 10.1128/jb.177.20.5732-5739.1995.
3
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.新型抗真菌(1,3)-β-D-葡聚糖合酶抑制剂的发现。
Antimicrob Agents Chemother. 2000 Feb;44(2):368-77. doi: 10.1128/AAC.44.2.368-377.2000.
4
cps1+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B.cps1+,一种粟酒裂殖酵母基因,是酿酒酵母FKS基因的同源物,其突变会导致对环孢菌素A和丘疹霉素B过敏。
J Bacteriol. 1997 Dec;179(24):7653-62. doi: 10.1128/jb.179.24.7653-7662.1997.
5
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.白色念珠菌FKS1基因被鉴定为1,3-β-D-葡聚糖合酶抑制剂的关键作用靶点。
Antimicrob Agents Chemother. 1997 Nov;41(11):2471-9. doi: 10.1128/AAC.41.11.2471.
6
Novel Cell Wall Antifungals Reveal a Special Synergistic Activity in Mutants Resistant to the Glucan Synthesis Antifungals Papulacandins and Echinocandins.新型细胞壁抗真菌药物在对葡聚糖合成抗真菌药物丘疹霉素和棘白菌素耐药的突变体中显示出特殊的协同活性。
Front Microbiol. 2019 Jul 24;10:1692. doi: 10.3389/fmicb.2019.01692. eCollection 2019.
7
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响:对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
8
Analysis of the Localization of Glucan Synthases in the Presence of the Antifungal Agent Caspofungin.分析抗真菌药物卡泊芬净存在时葡聚糖合成酶的定位。
Int J Mol Sci. 2023 Feb 21;24(5):4299. doi: 10.3390/ijms24054299.
9
Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.应激诱导β-(1,3)-d-葡聚糖合酶的脂微环境改变导致烟曲霉产生临床重要的棘白菌素类耐药性。
mBio. 2019 Jun 4;10(3):e00779-19. doi: 10.1128/mBio.00779-19.
10
Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.FKS基因在致病真菌对棘白菌素敏感性中的作用
Med Mycol J. 2018;59(2):E31-E40. doi: 10.3314/mmj.18.004.

引用本文的文献

1
Consensus paper on by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD.由土耳其共和国卫生部的土耳其EKMUD、ID-IRI、THSK、KLIMUD、TMC、TARD和TYBD发布的关于……的共识文件 (原文中“by”后面具体内容缺失)
Turk J Med Sci. 2025 Feb 2;55(4):1039-1062. doi: 10.55730/1300-0144.6059. eCollection 2025.
2
α-glucan remodeling by GH13-domain enzymes shapes fungal cell wall architecture.由GH13结构域酶介导的α-葡聚糖重塑塑造真菌细胞壁结构。
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2505509122. doi: 10.1073/pnas.2505509122. Epub 2025 Jul 16.
3
Solid-State NMR Analysis of Reveals Role of α-Amylase Family Enzymes in Cell Wall Structure and Function.对……的固态核磁共振分析揭示了α-淀粉酶家族酶在细胞壁结构与功能中的作用。 (原文中“of”后面缺少具体内容)
bioRxiv. 2025 Mar 10:2025.03.10.642465. doi: 10.1101/2025.03.10.642465.
4
Comparative Analysis of the Aspergillus fumigatus Cell Wall Modification and Ensuing Human Dendritic Cell Responses by β-(1,3)-Glucan Synthase Inhibitors-Caspofungin and Enfumafungin.比较烟曲霉细胞壁修饰及其对人树突状细胞反应的影响β-(1,3)-葡聚糖合成酶抑制剂-卡泊芬净和恩夫米芬。
Mycopathologia. 2024 Sep 20;189(5):86. doi: 10.1007/s11046-024-00894-7.
5
Pathogenesis, Prophylaxis, and Treatment of .……的发病机制、预防与治疗
Biomedicines. 2024 Mar 1;12(3):561. doi: 10.3390/biomedicines12030561.
6
Analysis of the Localization of Glucan Synthases in the Presence of the Antifungal Agent Caspofungin.分析抗真菌药物卡泊芬净存在时葡聚糖合成酶的定位。
Int J Mol Sci. 2023 Feb 21;24(5):4299. doi: 10.3390/ijms24054299.
7
Fission Yeast Rho1p-GEFs: From Polarity and Cell Wall Synthesis to Genome Stability.裂殖酵母 Rho1p-GEFs:从极性和细胞壁合成到基因组稳定性。
Int J Mol Sci. 2022 Nov 11;23(22):13888. doi: 10.3390/ijms232213888.
8
Update on the Pathogenesis, Virulence, and Treatment of .关于……的发病机制、毒力及治疗的最新进展 (原文不完整,此为根据现有内容尽量完整的翻译)
Pathog Immun. 2022 Oct 21;7(2):46-65. doi: 10.20411/pai.v7i2.535. eCollection 2022.
9
Echinocandin Drugs Induce Differential Effects in Cytokinesis Progression and Cell Integrity.棘白菌素类药物在胞质分裂进程和细胞完整性方面诱导不同的效应。
Pharmaceuticals (Basel). 2021 Dec 20;14(12):1332. doi: 10.3390/ph14121332.
10
Analysis and application of a suite of recombinant endo-β(1,3)-D-glucanases for studying fungal cell walls.用于研究真菌细胞壁的一组重组内切-β(1,3)-D-葡聚糖酶的分析与应用。
Microb Cell Fact. 2021 Jul 3;20(1):126. doi: 10.1186/s12934-021-01616-0.

本文引用的文献

1
Two tightly linked silent cassettes in the mating-type region of Schizosaccharomyces pombe.酿酒酵母交配型区的两个紧密连锁的沉默盒。
Curr Genet. 1984 Apr;8(3):199-203. doi: 10.1007/BF00417816.
2
The echinocandins: three useful choices or three too many?棘白菌素类药物:三种有用的选择还是太多了?
Int J Antimicrob Agents. 2010 Jan;35(1):13-8. doi: 10.1016/j.ijantimicag.2009.09.011. Epub 2009 Nov 25.
3
Fungal echinocandin resistance.真菌棘白菌素耐药性。
Fungal Genet Biol. 2010 Feb;47(2):117-26. doi: 10.1016/j.fgb.2009.09.003. Epub 2009 Sep 19.
4
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.光滑念珠菌FKS1和FKS2突变对棘白菌素敏感性及1,3-β-D-葡聚糖合酶动力学的影响:对现有药敏折点的意义
Antimicrob Agents Chemother. 2009 Sep;53(9):3690-9. doi: 10.1128/AAC.00443-09. Epub 2009 Jun 22.
5
Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae.Fks1在茄病镰刀菌内在棘白菌素抗性中的作用,通过在酿酒酵母中的杂交表达得以证明。
Antimicrob Agents Chemother. 2009 May;53(5):1772-8. doi: 10.1128/AAC.00020-09. Epub 2009 Mar 2.
6
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.白色念珠菌棘白菌素最低抑菌浓度(MIC)与fks1突变体葡聚糖合酶动力学抑制的相关性:对解释性断点的影响
Antimicrob Agents Chemother. 2009 Jan;53(1):112-22. doi: 10.1128/AAC.01162-08. Epub 2008 Oct 27.
7
In search of the holy grail of antifungal therapy.寻找抗真菌治疗的圣杯。
Trans Am Clin Climatol Assoc. 2008;119:197-215; discussion 215-6.
8
Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.白色念珠菌、热带念珠菌和克鲁斯念珠菌中fks1基因的突变,与采用欧洲抗生素敏感性试验委员会的方法在AM3培养基中发现的卡泊芬净最低抑菌浓度升高相关。
Antimicrob Agents Chemother. 2008 Sep;52(9):3092-8. doi: 10.1128/AAC.00088-08. Epub 2008 Jun 30.
9
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.近平滑念珠菌、正平滑念珠菌和副平滑念珠菌中Fks1p天然存在的脯氨酸到丙氨酸的氨基酸变化导致棘白菌素敏感性降低。
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.
10
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.念珠菌血症治疗期间因FKS1突变导致光滑念珠菌敏感性降低。
Antimicrob Agents Chemother. 2008 Jun;52(6):2263-5. doi: 10.1128/AAC.01568-07. Epub 2008 Mar 31.

三种特异性β(1,3)葡聚糖合酶抑制剂家族在裂殖酵母野生型和抗性菌株中的差异活性。

Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeast.

机构信息

Instituto de Microbiología Bioquímica, Consejo Superior de Investigaciones Científicas/Universidad de Salamanca, 37007 Salamanca, Spain.

出版信息

J Biol Chem. 2011 Feb 4;286(5):3484-96. doi: 10.1074/jbc.M110.174300. Epub 2010 Nov 29.

DOI:10.1074/jbc.M110.174300
PMID:21115488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3030354/
Abstract

Three specific β(1,3)glucan synthase (GS) inhibitor families, papulacandins, acidic terpenoids, and echinocandins, have been analyzed in Schizosaccharomyces pombe wild-type and papulacandin-resistant cells and GS activities. Papulacandin and enfumafungin produced similar in vivo effects, different from that of echinocandins. Also, papulacandin was the strongest in vitro GS inhibitor (IC(50) 10(3)-10(4)-fold lower than with enfumafungin or pneumocandin), but caspofungin was by far the most efficient antifungal because of the following. 1) It was the only drug that affected resistant cells (minimal inhibitory concentration close to that of the wild type). 2) It was a strong inhibitor of wild-type GS (IC(50) close to that of papulacandin). 3) It was the best inhibitor of mutant GS. Moreover, caspofungin showed a special effect for two GS inhibition activities, of high and low affinity, separated by 2 log orders, with no increase in inhibition. pbr1-8 and pbr1-6 resistances are due to single substitutions in the essential Bgs4 GS, located close to the resistance hot spot 1 region described in Saccharomyces and Candida Fks mutants. Bgs4(pbr)(1-8) contains the E700V change, four residues N-terminal from hot spot 1 defining a larger resistance hot spot 1-1 of 13 amino acids. Bgs4(pbr)(1-6) contains the W760S substitution, defining a new resistance hot spot 1-2. We observed spontaneous revertants of the spherical pbr1-6 phenotype and found that an additional A914V change is involved in the recovery of the wild-type cell shape, but it maintains the resistance phenotype. A better understanding of the mechanism of action of the antifungals available should help to improve their activity and to identify new antifungal targets.

摘要

已分析了棘白菌素类化合物的三种特定β(1,3)葡聚糖合酶(GS)抑制剂家族,即:多球壳菌素、酸性萜烯和棘白菌素,在野生型裂殖酵母和多球壳菌素抗性细胞以及 GS 活性中。多球壳菌素和恩夫霉素产生了相似的体内作用,与棘白菌素不同。此外,多球壳菌素是体外最强的 GS 抑制剂(IC50 比恩夫霉素或泊沙康唑低 103-104 倍),但卡泊芬净迄今为止是最有效的抗真菌药物,原因如下。1)它是唯一一种影响抗性细胞的药物(最小抑菌浓度接近野生型)。2)它是野生型 GS 的强抑制剂(IC50 接近多球壳菌素)。3)它是突变型 GS 的最佳抑制剂。此外,卡泊芬净对两种 GS 抑制活性具有特殊作用,这两种活性的亲和力相差 2 个对数级,但抑制作用没有增加。pbr1-8 和 pbr1-6 抗性是由于基本 Bgs4 GS 中的单个取代,该基因位于与 Saccharomyces 和 Candida Fks 突变体中描述的抗性热点 1 区域附近。Bgs4(pbr)(1-8) 包含 E700V 变化,距离热点 1 四个残基 N 端,定义了 13 个氨基酸的更大的热点 1-1。Bgs4(pbr)(1-6) 包含 W760S 取代,定义了新的热点 1-2。我们观察到了 pbr1-6 球形表型的自发回复突变体,并发现 A914V 变化参与了恢复野生型细胞形态,但它保持了抗性表型。更好地了解现有抗真菌药物的作用机制应有助于提高其活性并确定新的抗真菌靶标。